Live Biotherapeutics: Advancing Microbial Medicine
- 1st Edition, Volume 220 - February 20, 2026
- Latest edition
- Editor: Bhabatosh Das
- Language: English
Microbial therapeutics are rapidly reshaping modern medicine, with live biotherapeutics emerging as a promising frontier. By harnessing the power of beneficial microbes, these… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
Key features
Key features
- This book offers the first in-depth exploration of live biotherapeutics, addressing a critical gap in current scientific literature.
- It uniquely connects foundational biology with clinical and industrial advancements.
- The book meets urgent demand for alternative therapeutic strategies in microbial medicine.
Readership
Readership
Table of contents
Table of contents
Bhabatosh Das
1. Live Biotherapeutics: An Overview of Current Perspectives
Bhabatosh Das
2. Live Biotherapeutics and Nutraceuticals: Exploring Key Differences and Synergies
Amit Kumar Rai
3. Synthetic Biology and Recombinant Live Biotherapeutics: Current advancement
Vijai Singh
4. Personalized responses to live biotherapeutics
Tarini Shankar Shankar Ghosh
5. Clinical Applications of Live Biotherapeutics: Current Trends and Future Prospects
Dipasri Konar
6. Advancements in Technology for Developing Recombinant Live Biotherapeutics
Jyoti Verma
7. Recombinant Live Biotherapeutics as MicroBioreactor for Peptidal drug synthesis and delivery
Bhabatosh Das
8. Recombinant live biotherapeutics against chronic metabolic diseases: Challenges and opportunities
Dinesh Mahajan
9. Fecal Microbiota Transplantation in Liver Diseases: Therapeutic Potential and Associated Risks
Jayeeta Bhowmick
10. Bacteriophage-Based Live Biotherapeutics: A Novel Approach to Tackling Drug- Resistant Infectious Diseases
Christophe Possoz
11. The Human Reproductive Tract Microbiome: A Novel Source of Live Biotherapeutics
Lekshmi N
12. Recent Advances of Microbial Medicine to Prevent and Treat Cardiovascular Disease
Sanjay K. Banerjee
13. Microbiota-derived metabolites in immune disorders
Kiyoshi Takeda and Hisako Kayama
14. Live Biotherapeutics in Cancer Therapy
Punit Prasad
15. Recombinant Live Biotherapeutics for Neurological disorders
Tushar K. Maiti
16. Economic Impact and Commercialization of Live Biotherapeutics
Prabhuda Kundu
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 220
- Published: February 20, 2026
- Language: English
About the editor
About the editor
BD
Bhabatosh Das
Prof. Bhabatosh Das is a leading microbiologist and currently serves as a Professor at the BRIC-Translational Health Science and Technology Institute (THSTI), Faridabad. With a distinguished career in microbial genetics and functional genomics, he heads the Functional Genomics Laboratory, where his team focuses on the development of human microbiome-based biotherapeutics for metabolic disorders and strategies to combat extensively drug-resistant (XDR) bacterial infections by re-sensitizing resistant pathogens.
Prof. Das holds an M.Tech. in Biotechnology and Biochemical Engineering from the Indian Institute of Technology (IIT), Kharagpur, and earned his Ph.D. in Microbial Genetics from the Indian Institute of Chemical Biology (IICB), Kolkata. He further expanded his research portfolio through postdoctoral training at the CNRS-Institute of Integrative Biology for the Cell, France, where he specialized in microbial genomics and host-pathogen interactions.
His scientific contributions have earned national and international recognition. He was elected as a Fellow of the National Academy of Sciences, India, and also a Fellow of the West Bengal Academy of Science and Technology. In acknowledgment of his impactful work, he has been awarded two prestigious international fellowships, including one from the Japan Society for the Promotion of Science (JSPS), funded by the Government of Japan.
Prof. Das has an extensive research output, with over 160 peer-reviewed publications, two edited books, and more than nine Indian patents to his credit. His scholarly work spans a range of topics including antimicrobial resistance (AMR), host-microbiome interactions, and functional genomics, and has contributed significantly to shaping the understanding of microbiome-based interventions in health and disease.
In recognition of his outstanding research in the life sciences, Prof. Das received the SR-National Bioscience Award for Career Development (2023) from the Department of Biotechnology (DBT), Government of India—one of the highest national honors for scientists in the field of biosciences.
His current research focuses on microbial genomics to elucidate the dynamics of antimicrobial resistance and the development of next-generation biotherapeutics. Through translational research, he aims to bridge the gap between fundamental science and clinical application, addressing critical public health challenges such as multidrug resistance and metabolic disorders.
Prof. Das continues to inspire the scientific community through his dedication to excellence in research, mentorship, and innovation in translational microbiology and biotechnology.